Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1;107(6):1239-1242.
doi: 10.3324/haematol.2022.280920.

Introduction to a review series on the treatment of thrombocytopenic disorders: something old, something new

Francesco Rodeghiero  1
Affiliations

Introduction to a review series on the treatment of thrombocytopenic disorders: something old, something new

Francesco Rodeghiero. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Pathogenic mechanisms of congenital and acquired thrombocytopenia. The pathogenic mechanisms responsible for thrombocytopenia can be grouped into three categories: reduced production of platelets, increased consumption/destruction in the bloodstream, and increased destruction/entrapment in the spleen. The causes of thrombocytopenia are shown in the figure and many of them act through more than one pathogenic mechanism. Increased awareness of the many distinct forms of thrombocytopenia is a prerequisite for appropriate prevention, as in drug-associated thrombocytopenia, or for making a precise prognosis or planning comprehensive treatment exploiting as best possible the limited options available for the various different types of congenital and acquired thrombocytopenia.
See this image and copyright information in PMC

References

    1. Balduini C. Treatment of inherited thrombocytopenias. Haematologica. 2022;107(6):1278-1292. - PMC - PubMed
    1. Marini I, Uzun G, Jamal K, Bakchoul T. Treatment of drug-induced immune thrombocytopenias. Haematologica. 2022;107(6):1264-1277. - PMC - PubMed
    1. Kuter DJ. Treatment of chemotherapy-induced thrombocytopenia in patients with nonhematological malignancies. Haematologica. 2022;107(6):1243-1263. - PMC - PubMed
    1. Cines DB, Bussel JB. SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021;384(23):2254-2256. - PMC - PubMed
    1. Lee EJ, Beltrami-Moreira M, Al-Samkari H, et al. . SARS-CoV-2 Vaccination and immune thrombocytopenia in de novo and preexisting ITP patients. Blood. 2022;139(10):1564-1574. - PMC - PubMed